Northland Securities Downgrades Medifast (MED) to Market Perform
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Price: $12.16 +0.16%
Rating Summary:
4 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Rating Summary:
4 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Join SI Premium – FREE
Northland Securities downgraded Medifast (NYSE: MED) from Outperform to Market Perform, price target lowered from $32 to $17.
For more ratings news on Medifast click here and for the rating history of Medifast click here.
Shares of Medifast closed at $15.35 yesterday.
For more ratings news on Medifast click here and for the rating history of Medifast click here.
Shares of Medifast closed at $15.35 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler Double Downgrades Myriad Genetics (MYGN) to Underweight, 'Major Strategic Action Likely Needed'
- Morgan Stanley Downgrades Nordea Bank Abp (NDA:SS) (NRDBY) to Equalweight
- BofA Securities Downgrades Barclays Plc (BARC:LN) (BCS) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Northland SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
